Filing Analysis
Alto Ingredients, Inc. entered into an At-The-Market (ATM) issuance sales agreement to offer up to $50.0 million in common stock. The proceeds are intended for general corporate purposes, including working capital and capital expenditures.
🚩 Red Flags
- Potential dilution for existing shareholders through the issuance of new common stock.
- ATM offerings can create downward pressure on the stock price during the selling period.
📋 Key Facts
- Entered into Sales Agreement on August 5, 2026.
- Aggregate offering size: up to $50.0 million.
- Agents include Craig-Hallum Capital Group LLC (Designated Agent), The Benchmark Company, LLC, and H.C. Wainwright & Co., LLC.
- Commission rate for Agents is 3.0% of aggregate gross proceeds.
- Shares will be issued under an existing shelf registration statement (Form S-3) declared effective May 22, 2026.
Alto Ingredients, Inc. filed an 8-K to announce its results of operations for the three and six months ended June 30, 2026. The filing serves as a formal notice that a press release containing these financial results has been issued.
📋 Key Facts
- Reporting period: Three and six months ended June 30, 2026.
- Filing date: August 5, 2026.
- The company furnished (but did not file) a press release as Exhibit 99.1 containing the results.
Alto Ingredients, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on June 23, 2026. The meeting resulted in the election of five directors and the approval of several key shareholder proposals, including a new omnibus incentive plan.
📋 Key Facts
- Stockholders approved the 'Alto Ingredients, Inc. 2026 Omnibus Incentive Plan' (the '2026 Plan'), which allows for the issuance of up to 7,000,000 shares of common stock in various equity forms.
- Five directors were elected: Gilbert E. Nathan, Bryon T. McGregor, Dianne S. Nury, Maria G. Gray, and Alan R. Tank.
- Shareholders approved 'Say-on-Pay' compensation for named executive officers (25,740,806 votes in favor).
- RSM US LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- The 2026 Omnibus Incentive Plan is set to remain in effect until June 23, 2036.
Alto Ingredients, Inc. announced its financial results for the first quarter ended March 31, 2026, through a press release issued on May 6, 2026. The filing serves as a standard disclosure of quarterly operations and financial condition.
📋 Key Facts
- Reported results for the three months ended March 31, 2026.
- Press release issued and furnished on May 6, 2026.
- The information was furnished under Item 2.02 and is not deemed 'filed' for purposes of Section 18 of the Exchange Act.
Alto Ingredients, Inc. announced its financial results for the fourth quarter and full year ended December 31, 2025, via a press release on March 4, 2026.
📋 Key Facts
- The filing reports results for the three and twelve months ended December 31, 2025.
- The press release was furnished as Exhibit 99.1 under Item 2.02.
- The information is furnished and not deemed 'filed' for purposes of Section 18 of the Exchange Act.
Alto Ingredients, Inc. announced the resignation of Jeremy T. Bezdek from his position on the Board of Directors and all associated committees, effective November 24, 2025.
📋 Key Facts
- Jeremy T. Bezdek resigned from the Board of Directors on November 24, 2025.
- The resignation includes removal from all committees on which he served.
- The Company explicitly stated that the resignation was not due to any disagreement regarding operations, policies, or practices.
Alto Ingredients, Inc. filed an 8-K to announce its results of operations for the three and nine months ended September 30, 2025. The filing serves as a formal notice that a press release containing these financial results has been issued.
📋 Key Facts
- Report date: November 5, 2025
- Reporting period: Three and nine months ended September 30, 2025
- The filing includes Exhibit 99.1 (Press Release) which contains the actual financial results.
- Information furnished under Item 2.02 is not considered 'filed' for purposes of Section 18 liability.
Alto Ingredients, Inc. filed an 8-K to announce its results of operations for the three and six months ended June 30, 2025. The filing serves as a formal announcement of quarterly earnings via a press release.
📋 Key Facts
- Reporting period: Three and six months ended June 30, 2025.
- Filing date: August 6, 2025.
- The results were announced via a press release (Exhibit 99.1) which is furnished but not filed.
Alto Ingredients, Inc. has successfully regained compliance with Nasdaq's minimum bid price requirement under Listing Rule 5550(a)(2). The company received notification from Nasdaq that the matter regarding its stock price deficiency is now closed.
🚩 Red Flags
- Historical delisting risk (though now resolved)
📋 Key Facts
- The Company was previously in violation of Nasdaq Listing Rule 5550(a)(2) due to a minimum bid price requirement.
- As of June 23, 2025, the company's common stock closed above $1.00 for the last 10 consecutive business days.
- Nasdaq has officially stated that the Company has regained compliance and the matter is closed.
Alto Ingredients, Inc. held its 2025 Annual Meeting of Stockholders on June 25, 2025. The meeting resulted in the election of six directors and the approval of several shareholder proposals, including executive compensation and auditor ratification.
🚩 Red Flags
- None identified in this filing.
📋 Key Facts
- The 2025 Annual Meeting of Stockholders was held on June 25, 2025.
- Six directors were elected: Bryon T. McGregor, Maria G. Gray, Gilbert E. Nathan, Dianne S. Nury, Jeremy T. Bezdek, and Alan R. Tank.
- Shareholders approved the 'say-on-pay' advisory vote regarding 2024 executive compensation with 20,574,474 votes in favor.
- Shareholders voted to recommend conducting an advisory vote on executive compensation every one, two, or three years; the majority favored a one-year cycle (19,674,028 votes).
- RSM US LLP was ratified as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.
Alto Ingredients, Inc. received a notice from Nasdaq indicating that its common stock has failed to meet the $1.00 minimum bid price requirement for continued listing. The company has been granted an initial 180-day compliance period ending November 15, 2025.
🚩 Red Flags
- Delisting notice from Nasdaq
- Failure to maintain minimum bid price requirement ($1.00)
- Potential for mandatory reverse stock split to regain compliance
📋 Key Facts
- Nasdaq issued a deficiency notice on May 19, 2025, due to the stock closing below $1.00 for 30 consecutive business days.
- The company has an initial compliance period of 180 calendar days, expiring November 15, 2025.
- To regain compliance, the stock must close at $1.00 or more for a minimum of 10 consecutive business days.
- A second 180-day extension may be available if market value requirements are met and the company intends to cure the deficiency via a reverse stock split.
Alto Ingredients, Inc. filed an 8-K to announce its results of operations for the first quarter ended March 31, 2025. The filing serves as a formal notice that a press release containing these financial results has been issued.
📋 Key Facts
- Report date: May 7, 2025
- Reporting period: Three months ended March 31, 2025
- The filing includes Exhibit 99.1 (Press Release) regarding results of operations.
- Information furnished under Item 2.02 is not considered 'filed' for purposes of Section 18 liability.
Alto Ingredients entered into a settlement letter agreement with the Radoff/Torok Group to resolve potential board representation conflicts. The agreement includes the departure of two directors and imposes significant standstill provisions on the Radoff/Torok Group.
🚩 Red Flags
- Settlement with an activist group (Radoff/Torok) suggests recent or ongoing proxy contest tension.
- Departure of two board members (including the Chairman, Douglas L. Kieta) simultaneously.
- Significant restrictions placed on a major shareholder group to prevent future contested solicitations.
📋 Key Facts
- On March 17, 2025, Alto Ingredients entered into a Letter Agreement with Bradley L. Radoff and Michael Torok (the 'Radoff/Torok Group').
- Board members Douglas L. Kieta and Michael D. Kandris will not stand for re-election at the 2025 Annual Meeting.
- The Board maintains sole discretion to appoint successors to fill the vacancies created by Kieta and Kandris.
- The Radoff/Torok Group is subject to a 'Standstill Period' during which they must vote in favor of all Board-nominated directors.
- Standstill provisions include a 19.9% ownership cap and prohibitions on nominating directors, making merger proposals, or initiating proxy contests.
- A non-disparagement clause applies to both parties during the Restricted Period.
Alto Ingredients, Inc. filed an 8-K to announce its results of operations for the three and twelve months ended December 31, 2024. The filing serves as a formal notice that a press release containing these financial results has been issued.
📋 Key Facts
- Report date: March 5, 2025
- Reporting period: Three and twelve months ended December 31, 2024
- The filing includes an earnings press release as Exhibit 99.1
- Information under Item 2.02 is furnished but not filed for purposes of Section 18 liability
Alto Ingredients, Inc., through its subsidiary Alto Pekin, LLC, entered into a CO2 Transportation and Sequestration Agreement with Vault Dragon CCS Holdings LP. The agreement aims to facilitate the delivery of carbon dioxide for permanent sequestration to enable the company to claim tax credits.
📋 Key Facts
- Agreement date: November 5, 2024
- Parties: Alto Pekin, LLC (subsidiary) and Vault Dragon CCS Holdings LP
- Purpose: Delivery of a composite of CO2 and other components through facilities to be constructed/operated by Vault
- Objective: To qualify for, claim, and receive certain tax credits and other benefits related to carbon sequestration
Alto Ingredients, Inc. filed an 8-K to announce its results of operations for the three and nine months ended September 30, 2024. The filing serves as a formal announcement of the quarterly earnings release.
📋 Key Facts
- Report date: November 6, 2024
- Reporting period: Three and nine months ended September 30, 2024
- The company issued a press release (Exhibit 99.1) containing the results of operations.
- Information furnished under Item 2.02 is not deemed 'filed' for purposes of Section 18 liability.
Alto Ingredients, Inc. issued an 8-K to announce its results of operations for the three and six months ended June 30, 2024. The filing serves as a formal notice that a press release containing these financial results was issued on August 6, 2024.
📋 Key Facts
- Report date: August 6, 2024
- Reporting period: Three and six months ended June 30, 2024
- The filing is under Item 2.02 (Results of Operations and Financial Condition)
- Financial results were furnished via press release (Exhibit 99.1) rather than filed.
Alto Ingredients, Inc. held its 2024 Annual Meeting of Stockholders on June 20, 2024. The meeting resulted in the election of six directors and the approval of several shareholder proposals including executive compensation and an amendment to the stock incentive plan.
🚩 Red Flags
- Proposal Three (Stock Incentive Plan increase) received significant opposition with 10,889,086 votes against, suggesting shareholder concern regarding dilution.
📋 Key Facts
- Annual Meeting held on June 20, 2024.
- Six directors elected: Douglas L. Kieta, Bryon T. McGregor, Michael D. Kandris, Maria G. Gray, Gilbert E. Nathan, and Dianne S. Nury.
- Shareholders approved 'say-on-pay' regarding 2023 executive compensation (26,055,415 votes for).
- Shareholders approved an amendment to the 2016 Stock Incentive Plan to increase authorized shares from 11.4M to 15.2M.
- Ratification of RSM US LLP as independent registered public accounting firm for fiscal year ending Dec 31, 2024.
Alto Ingredients, Inc. issued a press release announcing its financial results for the first quarter ended March 31, 2024.
📋 Key Facts
- Report date: May 6, 2024
- Reporting period: Three months ended March 31, 2024
- The filing is an announcement of results of operations and financial condition (Item 2.02).
Alto Ingredients, Inc. announced the adoption of a new performance-based equity incentive compensation program for its executive officers. The program ties restricted stock awards to Adjusted EBITDA return on gross fixed assets (ROA) targets over a three-year period.
🚩 Red Flags
- Potential dilution of existing shareholders through the issuance of restricted stock upon meeting performance targets.
📋 Key Facts
- The Compensation Committee adopted a performance-based equity incentive program effective March 20, 2024.
- Performance metric: Adjusted EBITDA ROA (Adjusted EBITDA divided by average gross fixed assets after deducting construction in progress and capitalized interest).
- 2024 Performance Targets: Threshold 4.80%, Target 5.20%, Maximum 5.60%.
- Awards are split over three years: 33% for 2024, 33% for 2025, and 34% for 2026.
- Performance awards require additional time-based vesting through early 2027.
- Specific grants were issued to Bryon T. McGregor (CEO), Robert R. Olander, Auste M. Graham, and James R. Sneed.
Alto Ingredients announced the resignation of Interim Chief Operating Officer Michael D. Kandris and the appointment of Todd E. Benton as the new permanent Chief Operating Officer, effective April 1, 2024.
🚩 Red Flags
- Leadership transition: The departure of an interim officer often signals a period of organizational restructuring or uncertainty, though the planned retirement suggests an orderly succession.
📋 Key Facts
- Michael D. Kandris to resign as Interim COO on April 1, 2024; will remain for a transition period until retirement on June 20, 2024.
- Todd E. Benton appointed as permanent COO effective April 1, 2024.
- Benton's compensation includes a $350,000 annual base salary and various short-term and long-term incentive targets.
- Kandris's employment agreement was amended to remove all severance benefits in light of his resignation/retirement.
Alto Ingredients, Inc. filed an 8-K to announce its results of operations and financial condition for the three and twelve months ended December 31, 2023.
📋 Key Facts
- Report date: March 11, 2024
- Reporting period: Three and twelve months ended December 31, 2023
- The filing includes a press release (Exhibit 99.1) detailing financial results.
- Information under Item 2.02 is furnished but not filed for purposes of Section 18 liability.
Alto Ingredients, Inc. announced that its Board of Directors approved and adopted amended and restated bylaws effective February 29, 2024. The changes primarily address universal proxy rules, advance notice procedures, and forum selection for securities litigation.
📋 Key Facts
- Board approved Amended and Restated Bylaws on February 29, 2024.
- Amendments include revised disclosure requirements for advance notice bylaw provisions.
- Bylaws updated to address SEC universal proxy rules (Rule 14a-19).
- New requirement: stockholders soliciting proxies must use a non-white proxy card color.
- Eliminated the requirement to make stockholder lists available for examination at meetings per Delaware law changes.
- Established U.S. federal district courts as the exclusive forum for Securities Act of 1933 claims.